Key Stats

Expense Ratio Discount or Premium to NAV Total Assets Under Management 30-Day Average Daily Volume
1.09% 0.20% 77.79M 7.547M
Dividend Yield Turnover Ratio 1 Year Fund Level Flows Max Drawdown (All)
1.42% 0.00% 99.04M Upgrade

Basic Info

Investment Strategy
The investment seeks daily investment results, before fees and expenses, of 300% of the inverse of the daily performance of the S&P Biotechnology Select Industry Index. The fund, under normal circumstances, invests at least 80% of its net assets (plus borrowing for investment purposes) in swap agreements, futures contracts, short positions or other financial instruments that provide inverse (opposite) or short daily exposure to the index or to ETFs that track the index. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
General
Security Type Exchange-Traded Fund
Equity Style --
Fixed Income Style --
Broad Asset Class Miscellaneous
Broad Category Miscellaneous
Category Name Trading--Inverse Equity
Category Index S&P 500 TR USD
Global Category Name Trading Tools
YCharts Categorization Other
YCharts Benchmark S&P 500 Total Return (^SPXTR)
Prospectus Objective Specialty - Technology
Fund Owner Firm Name Direxion Funds
Prospectus Benchmark Index
S&P Biotechnology Select Industry TR USD -300.0%
Broad Asset Class Benchmark Index
^SPXTR 100.0%
Manager Tenure
Paul Brigandi 7.76 yrs
Tony Ng 7.42 yrs

Net Fund Flows Versus Category

View Net Fund Flows. Upgrade now.
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
 
80.00B
60.00B
40.00B
20.00B
0
-20.00B
1 Month
% Rank: --
-- Category Low
-- Category High
1 Year
% Rank: 19
99.04M
-122.92M Category Low
2.267B Category High
3 Months
% Rank: --
-- Category Low
-- Category High
3 Years
% Rank: --
-- Category Low
-- Category High
6 Months
% Rank: --
-- Category Low
-- Category High
5 Years
% Rank: --
-- Category Low
-- Category High
YTD
% Rank: --
-- Category Low
-- Category High
10 Years
% Rank: --
-- Category Low
-- Category High
As of February 28, 2023

Performance Versus Category

 
20%
15%
10%
5%
0
View Category Returns. Upgrade now.
Name
1M
3M
YTD
1Y
3Y
5Y
10Y
15Y
Total Return (Price)
--
--
--
--
--
--
--
--
Total Return (NAV)
--
--
--
--
--
--
--
--
Category Rtn. (NAV)
--
--
--
--
--
--
--
--
% Rank in Cat (NAV)
--
--
--
--
--
--
--
--
As of March 24, 2023. Returns for periods of 1 year and above are annualized.

Annual Total Returns Versus Peers

Loading chart...
Name
2016
2017
2018
2019
2020
2021
2022
YTD
-39.05%
-75.67%
-6.26%
-70.81%
-89.74%
1.86%
-32.66%
31.73%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-18.11%
3.86%
-62.90%
149.1%
-57.60%
75.51%
74.66%
-64.15%
-80.36%
-35.36%
--
--
--
--
-87.18%
-39.82%
117.1%
-41.33%
-18.84%
-49.76%
12.46%
-29.02%
-39.47%
23.56%
-11.73%
-8.61%
-33.28%
-31.70%
16.43%
-42.98%
-42.40%
-73.83%
17.63%
12.67%
As of March 24, 2023.

Fund Details

Key Dates
Inception Date 5/28/2015
Last Annual Report Date 10/31/2022
Last Prospectus Date 2/28/2023
Attributes
Index Fund Yes
Inverse Fund Yes
Leveraged Fund Yes
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No

Asset Allocation

As of March 22, 2023.
Type % Net % Long % Short
Cash 115.9% Upgrade Upgrade
Stock -125.5% Upgrade Upgrade
Bond 0.00% Upgrade Upgrade
Convertible 0.00% Upgrade Upgrade
Preferred 0.00% Upgrade Upgrade
Other 109.7% Upgrade Upgrade

Top 4 Holdings

Name % Weight Price % Change
Dreyfus Government Secs Cash Mgmt Admin 149.8% 1.00 0.00%
Goldman Sachs Sterling FixInc Port Inc
109.7% -- --
Goldman Sachs FS Government Instl 25.10% 1.00 0.00%
S&P Biotechnology Select Industry Index Swap
-125.5% -- --

News

Headline
Wire
Time (ET)
SA Breaking News
03/25 10:21
SA Breaking News
02/11 10:30
SA Breaking News
12/10 10:25
SA Breaking News
11/19 10:30
SA Breaking News
08/20 10:36
SA Breaking News
07/09 08:15
SA Breaking News
06/25 10:25
SA Breaking News
06/04 02:36
SA Breaking News
04/30 10:40
SA Breaking News
04/23 10:20

Basic Info

Investment Strategy
The investment seeks daily investment results, before fees and expenses, of 300% of the inverse of the daily performance of the S&P Biotechnology Select Industry Index. The fund, under normal circumstances, invests at least 80% of its net assets (plus borrowing for investment purposes) in swap agreements, futures contracts, short positions or other financial instruments that provide inverse (opposite) or short daily exposure to the index or to ETFs that track the index. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
General
Security Type Exchange-Traded Fund
Equity Style --
Fixed Income Style --
Broad Asset Class Miscellaneous
Broad Category Miscellaneous
Category Name Trading--Inverse Equity
Category Index S&P 500 TR USD
Global Category Name Trading Tools
YCharts Categorization Other
YCharts Benchmark S&P 500 Total Return (^SPXTR)
Prospectus Objective Specialty - Technology
Fund Owner Firm Name Direxion Funds
Prospectus Benchmark Index
S&P Biotechnology Select Industry TR USD -300.0%
Broad Asset Class Benchmark Index
^SPXTR 100.0%
Manager Tenure
Paul Brigandi 7.76 yrs
Tony Ng 7.42 yrs

Fund Details

Key Dates
Inception Date 5/28/2015
Last Annual Report Date 10/31/2022
Last Prospectus Date 2/28/2023
Attributes
Index Fund Yes
Inverse Fund Yes
Leveraged Fund Yes
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No

News

Headline
Wire
Time (ET)
SA Breaking News
03/25 10:21
SA Breaking News
02/11 10:30
SA Breaking News
12/10 10:25
SA Breaking News
11/19 10:30
SA Breaking News
08/20 10:36
SA Breaking News
07/09 08:15
SA Breaking News
06/25 10:25
SA Breaking News
06/04 02:36
SA Breaking News
04/30 10:40
SA Breaking News
04/23 10:20

Top Portfolio Holders

0 of 0